Cognition and Memory Enhancement Drugs Market, Global Scenario, Market Size, Outlook, Trend, and Forecast, 2016 – 2025

Global Cognition and Memory Enhancement Drugs Market is expected to grow at a CAGR of 8.8% from 2017 to 2025. The report highlights the key trends, market outlook and the global scenario of the Global Cognition and Memory Enhancement Drugs Market. The market sizing is provided from 2016 to 2025, wherein the forecast is provided from 2017 to 2025. In addition, market dynamics (i.e. market drivers, market restraints and market opportunities) which covers factors supporting the market growth, factors restraining the market growth and factors behind the opportunities across this industry in the coming years has been included extensively under the scope of the study. The report also provides extensive detail of the market segments across type, application, and geography; market share of the key players globally and the competitive scenario throughout the forecast period, industry expert opinion, and profiles of the key players in the market. The major key players of the market are as follows:

KEY PLAYERS

ACCELERATED INTELLIGENCE INC.

ALLERGAN PLC

ALTERNASCRIPT LLC

CAMBRIDGE COGNITION

CERETROPIC

COGNITION THERAPEUTICS INC.

COGSTATE LTD.

HVMN

NOOTRIMENT

NOVARTIS AG

ONNIT LABS LLC

PEAK NOOTROPICS

PFIZER INC.

PURELIFE BIOSCIENCE CO., LTD.

SHIRE

SUPNOOTROPIC BIO CO., LTD.

TEVA PHARMACEUTICALS INDUSTRIES LTD. (BARR PHARMACEUTICALS)

Scope of the Market

Product Type Market

ADHD, Attention Deficit Hyperactivity Disorder; MPH, Methylphenidate

Global Cognition and Memory-enhancing Drugs Market

Application Market

Alzheimer's Disease

Education Sector

Sports

Other Applications

Geography Market

North America

Europe

Asia-Pacific

ROW

Back to top

Payment Options

Single User : $3897 $2,923
Five User: $5175
$3,881
Enterprise : $9135 $6,851